Cargando…

Routine application of the Lymph2Cx assay for the subclassification of aggressive B-cell lymphoma: report of a prospective real-world series

The subclassification of diffuse large B-cell lymphoma (DLBCL) into germinal center B-cell-like (GCB) and activated B-cell-like (ABC) subtypes has become mandatory in the 2017 update of the WHO classification of lymphoid neoplasms and will continue to be used in the WHO 5(th) edition. The RNA-based...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zamò, Alberto, Gerhard-Hartmann, Elena, Ott, German, Anagnostopoulos, Ioannis, Scott, David W., Rosenwald, Andreas, Rauert-Wunderlich, Hilka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734243/ https://www.ncbi.nlm.nih.gov/pubmed/36219238 http://dx.doi.org/10.1007/s00428-022-03420-6

Ejemplares similares

Targeted panel sequencing in the routine diagnosis of mature T- and NK-cell lymphomas: report of 128 cases from two German reference centers
por: Böck, Julia, et al.
Publicado: (2023)

CD40L mediated alternative NFκB-signaling induces resistance to BCR-inhibitors in patients with mantle cell lymphoma
por: Rauert-Wunderlich, Hilka, et al.
Publicado: (2018)

CD52 and OXPHOS—potential targets in ibrutinib-treated mantle cell lymphoma
por: Fuhr, Viktoria, et al.
Publicado: (2022)

Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironment
por: Rudelius, Martina, et al.
Publicado: (2018)

Time-Resolved scRNA-Seq Tracks the Adaptation of a Sensitive MCL Cell Line to Ibrutinib Treatment
por: Fuhr, Viktoria, et al.
Publicado: (2021)

PB2380: DEVELOPING GENOMIC TESTS THAT GUIDE LARGE B-CELL LYMPHOMA DIAGNOSIS AND TREATMENT: LYMPH2CX AND LYMPH3CX ASSAYS
por: Robetorye, Ryan S., et al.
Publicado: (2023)

A case of nodular lymphocyte predominant Hodgkin lymphoma with unexpected EBV-latency type
por: Rosenfeldt, Mathias T., et al.
Publicado: (2020)

Follicular lymphoma subgroups with and without t(14;18) differ in their N-glycosylation pattern and IGHV usage
por: Leich, Ellen, et al.
Publicado: (2021)

The IKK Inhibitor Bay 11-7082 Induces Cell Death Independent from Inhibition of Activation of NFκB Transcription Factors
por: Rauert-Wunderlich, Hilka, et al.
Publicado: (2013)

Identification of Methylated Genes Associated with Aggressive Clinicopathological Features in Mantle Cell Lymphoma
por: Enjuanes, Anna, et al.
Publicado: (2011)

Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinoma
por: Overman, Michael J., et al.
Publicado: (2016)

Chinese Ischemic Stroke Subclassification
por: Gao, S., et al.
Publicado: (2011)

The Evolution of Ovarian Carcinoma Subclassification
por: Köbel, Martin, et al.
Publicado: (2022)

Diffuse large B-cell non-Hodgkin lymphomas: the clinical relevance of histological subclassification
por: Baars, J W, et al.
Publicado: (1999)

Diagnosis and Subclassification of Acute Lymphoblastic Leukemia
por: Chiaretti, Sabina, et al.
Publicado: (2014)

Interphysician agreement on subclassification of myocardial infarction
por: Gard, Anton, et al.
Publicado: (2018)

Cell-of-origin of diffuse large B-cell lymphomas determined by the Lymph2Cx assay: better prognostic indicator than Hans algorithm
por: Yoon, Nara, et al.
Publicado: (2017)

The NEDD8-activating enzyme inhibitor MLN4924 sensitizes a TNFR1(+) subgroup of multiple myeloma cells for TNF-induced cell death
por: El-Mesery, Mohamed, et al.
Publicado: (2019)

B lymphoblastic leukemia/lymphoma: new insights into genetics, molecular aberrations, subclassification and targeted therapy
por: Zhang, Xiaohui, et al.
Publicado: (2017)

A cytomorphological and immunohistochemical profile of aggressive B-cell lymphoma: high clinical impact of a cumulative immunohistochemical outcome predictor score
por: Höller, Sylvia, et al.
Publicado: (2009)

The symptomatic localization-related epilepsies: problems with subclassification.
por: Williamson, P. D.
Publicado: (1987)

Pathobiological and Radiological Approach For Hepatocellular Carcinoma Subclassification
por: Vasuri, Francesco, et al.
Publicado: (2019)

Proposal of a T3 Subclassification for Colon Carcinoma
por: Merkel, Susanne, et al.
Publicado: (2022)

P1287: DISTINGUISHING BETWEEN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA AND DIFFUSE LARGE B-CELL LYMPHOMA USING THE LYMPH3CX GENE EXPRESSION PROFILING ASSAY
por: Robetorye, R. S., et al.
Publicado: (2022)

R-CHOP intensification with mid-cycle methotrexate and consolidating AraC/TT with BCNU/aHSCT in primary aggressive lymphoma with CNS involvement
por: Steinhardt, Maximilian J., et al.
Publicado: (2021)

Is Preoperative Subclassification of Type I Choledochal Cyst Necessary?
por: Jung, Kyuwhan, et al.
Publicado: (2012)

Subclassification of Newly Diagnosed Glioblastomas through an Immunohistochemical Approach
por: Conroy, Siobhan, et al.
Publicado: (2014)

Evolution and current status of the subclassification of intermediate hepatocellular carcinoma
por: Yi, Peng-Sheng, et al.
Publicado: (2020)

The role of pyroptosis-related genes in the diagnosis and subclassification of sepsis
por: Ding, Wencong, et al.
Publicado: (2023)

Integrative genomic analysis focused on cell cycle genes for MYC-driven aggressive mature B-cell lymphoma
por: Yamashita, Takahisa, et al.
Publicado: (2020)

Molecular profiling of EBV associated diffuse large B-cell lymphoma
por: Frontzek, Fabian, et al.
Publicado: (2023)

Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas
por: Schrader, Anne M. R., et al.
Publicado: (2022)

Divide and conquer: the genetic basis of molecular subclassification of breast cancer
por: Kristensen, Vessela N
Publicado: (2011)

Gene content dissimilarity for subclassification of highly similar microbial strains
por: Tu, Qichao, et al.
Publicado: (2016)

Do the Data Support Manometric Subclassifications for Ineffective Esophageal Motility?
por: Singhal, Saurabh, et al.
Publicado: (2017)

Usefulness of subclassification of adult diabetes mellitus among inpatients in Japan
por: Saito, Kohei, et al.
Publicado: (2021)

Incorporating circulating cytokines into the idiopathic inflammatory myopathy subclassification toolkit
por: De Paepe, Boel
Publicado: (2023)

MDS subclassification—do we still have to count blasts?
por: Huber, Sandra, et al.
Publicado: (2023)

Precision subclassification of type 2 diabetes: a systematic review
por: Misra, Shivani, et al.
Publicado: (2023)

A peculiar case of primary central nervous system T-cell lymphoma with indolent behavior
por: Wasilewski, David, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jnqf3tpfn8h2b09agu9vjcvqa0